FDA scientists appear to offer major endorsement of Biogen’s controversial Alzheimer’s treatment
STAT+ subscribers will have access to all-day coverage of the Friday advisory committee meeting to discuss Biogen’s Alzheimer’s drug, with regular updates on key presentations, interesting arguments, and eventually the …
Read More